NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
50 hedge funds and large institutions have $3.91M invested in Nymox Pharmaceutical Corp in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
70% less capital invested
Capital invested by funds: $13.1M → $3.91M (-$9.23M)
Holders
50
Holding in Top 10
–
Calls
$60K
Puts
$20K
Top Buyers
| 1 | +$485K | |
| 2 | +$294K | |
| 3 | +$239K | |
| 4 |
HF
HRT Financial
New York
|
+$189K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$117K |
Top Sellers
| 1 | -$2.79M | |
| 2 | -$984K | |
| 3 | -$826K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$453K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$408K |